Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect
about
Pulmonary arterial hypertension: a comparison between children and adultsAdult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentanLong-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease.Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome.Shear stress, energy losses, and costs: a resolved dilemma of pulsatile cardiac assist devices.The challenge of managing pulmonary arterial hypertension in adults with congenital heart disease.Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism.Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial.Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension.Advanced therapies for the management of adults with pulmonary arterial hypertension due to congenital heart disease: a systematic review.Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.Adult congenital heart disease and pulmonary arterial hypertension: the Texas Adult Congenital Heart Program experience.Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension
P2860
Q27687320-435C635C-DAC0-4C3C-8506-BD961BEB5377Q34133301-5443A297-4967-4627-BF74-33F42A182A67Q34991800-E933502A-F17D-423C-8027-60D412AFDE87Q36611236-A9301414-FDFD-43CD-8878-882194B7DF6FQ37553593-3DCE66EE-7EA2-4F89-AAFE-66D689E2AA9FQ38124878-47DB408D-7BDE-4FE0-BCFB-5ABA5D9B5DE4Q42284467-881F80CD-D9D3-42F3-BF95-BE758B7B3BACQ43142741-85C9A170-0F0F-423A-A69E-A616DFCC63BCQ46222874-D70D60E4-6E8F-47DA-BF01-41BE79A85DD3Q47561539-6444CA9B-63DA-4F93-AABC-6C16FA069892Q51047681-32C62BF7-A0F9-4309-91C3-64ABDC145579Q51493465-E3A9D0F8-0EDE-4419-9C02-EDD696AD8367Q58067345-8D2CB30B-B2AC-4E90-8210-D6A6137DD6BF
P2860
Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Long term effects of bosentan ...... nical, and haemodynamic effect
@ast
Long term effects of bosentan ...... nical, and haemodynamic effect
@en
type
label
Long term effects of bosentan ...... nical, and haemodynamic effect
@ast
Long term effects of bosentan ...... nical, and haemodynamic effect
@en
prefLabel
Long term effects of bosentan ...... nical, and haemodynamic effect
@ast
Long term effects of bosentan ...... nical, and haemodynamic effect
@en
P2093
P2860
P356
P1433
P1476
Long term effects of bosentan ...... nical, and haemodynamic effect
@en
P2093
F Ferrante
P Argiento
P2860
P304
P356
10.1136/HRT.2006.097360
P407
P577
2006-11-29T00:00:00Z